查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1533633

3D 生物列印市場規模、佔有率和成長分析：按組件、按材料、按技術、按地區 - 行業預測，2024-2031 年

3D Bioprinting Market Size, Share, Growth Analysis, By Component (3D Bioprinters, Bioinks), By Material (Living Cell, Hydrogel), By Technology (Inkjet-based, Magnetic Levitation), By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球3D生物列印市場規模將達到10.8億美元，從2023年的13億美元成長到2031年的59.2億美元，預計在預測期間（2024-2031年）成長。 。

器官移植市場的成長動力是器官捐贈者的短缺和患有慢性呼吸道疾病的人口老化。研究和開發投資的增加、技術進步以及慢性病盛行率的上升預計將在預測期內推動市場擴張。 3D 列印由於能夠製造用於移植的腎臟、心臟和肺部等複雜器官，因此在醫學領域變得越來越重要。與傳統的器官移植有被接受者身體排斥的風險不同，3D列印器官使用來自患者自身血液的細胞，降低了排斥的風險。這項技術可以創造新的器官和修復骨折，在醫學上具有廣闊的前景。此外，3D生物列印能夠生產義肢來取代失去的腿，為需要捐贈器官的傳統方法提供更快、更有效的替代方案。對器官的高需求和捐贈者數量有限之間的差距導致移植等待時間很長。為了應對這項挑戰，科學家們正在努力開發人造器官。然而，目前的人造器官尚不適合人體移植。這種供需之間的差距正在推動3D列印器官的發展，旨在滿足器官移植領域未滿足的商業性需求。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 次要/一級資訊來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 貿易分析
  • 專利分析
  • 市場生態系統
  • 客戶和購買標準分析
  • 監管環境
  • PESTEL分析
  • 創新矩陣
  • 重點投資分析
  • 關鍵成功因素
  • 市場魅力指數
  • 競爭程度

3D 生物列印市場：按組成部分

  • 市場概況
  • 3D生物列印機
    • 微擠壓生物印表機
    • 噴墨3D生物列印機
    • 雷射輔助生物印表機
    • 基於立體光刻技術的生物印表機
    • 磁性3D生物列印機
    • 其他
  • 生物墨水
    • 天然生物墨水
    • 混合生物墨水
    • 合成生物墨水
  • 軟體
  • 消耗品

3D 生物列印市場：依材料分類

  • 市場概況
  • 活細胞
  • 水凝膠
  • 細胞外基質
  • 其他

3D 生物列印市場：依應用分類

  • 市場概況
  • 研究用途
    • 藥物研究
    • 再生醫學
    • 3D細胞培養
  • 臨床應用
    • 皮膚
    • 骨/軟骨
    • 血管
    • 其他

3D 生物列印市場：依技術分類

  • 市場概況
  • 磁浮
  • 噴墨底座
  • 注射器底座
  • 雷射基地
  • 其他

3D 生物列印市場：依最終用戶分類

  • 市場概況
  • 學術/研究機構
  • 製藥和生物技術公司
  • 醫院

3D 生物列印市場規模：按地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 英國
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位（2023年）
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率（2023年）

主要企業簡介

  • Organovo Holdings, Inc.（US）
  • 3D Systems, Inc.（US）
  • CELLINK AB（Sweden）
  • Stratasys Ltd.（US）
  • Rokit Healthcare（Korea）
  • Poietis SAS（France）
  • Aspect Biosystems Ltd.（Canada）
  • Cyfuse Biomedical KK（Japan）
  • Tissuelabs（Switzerland）
  • Advanced Solutions, Inc.（US）
  • RegenHU Ltd.（Switzerland）
  • Materialise NV（Belgium）
  • Microdrop Technologies GmbH（Germany）
  • GeSiM mbH（Germany）
  • 3D Biotek, LLC（US）
  • REGEMAT 3D, SL（Spain）
  • POIETIS（France）
  • SUNP BIOTECH（China）
  • MEDPRIN（China）
  • PRODWAYS（France）
簡介目錄
Product Code: SQMIG20I2072

Global 3D Bioprinting Market size was valued at USD 1.08 Billion in 2022 and is poised to grow from USD 1.3 Billion in 2023 to USD 5.92 Billion by 2031, growing at a CAGR of 20.8% in the forecast period (2024-2031).

The growth of the organ transplantation market is driven by a shortage of organ donors and an aging population with chronic respiratory diseases. Increased investment in research and development, technological advancements, and the rising prevalence of chronic illnesses are expected to fuel market expansion over the forecast period. 3D printing is gaining significance in the medical field for its ability to produce complex organs such as kidneys, hearts, and lungs for transplants. Unlike traditional organ transplants, which risk rejection by the recipient's body, 3D-printed organs use cells derived from the patient's own blood, reducing the risk of rejection. This technology holds great promise in medicine, allowing for the creation of new organs and the repair of fractured bones. Moreover, 3D bioprinting enables the production of prosthetic limbs to replace lost legs, offering a faster and more efficient alternative compared to traditional methods that require donor organs. The disparity between the high demand for organs and the limited number of donors results in longer waiting times for transplants. To address this challenge, scientists are working on developing synthetic organs. However, current synthetic organs are not yet suitable for human transplantation. This gap between demand and supply is driving the advancement of 3D-printed organs, aiming to meet the unmet commercial needs in the field of organ transplantation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global 3D Bioprinting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global 3D Bioprinting Market Segmental Analysis

Global 3D bioprinting market is segmented based on Component, Material, Application, Technology, End-user, and Region. Based on Component, the market is segmented into 3D Bioprinters (Micro Extrusion Bioprinters, Inkjet 3d Bioprinters, Laser-assisted Bioprinters, Stereolithography-based Bioprinters, Magnetic 3d Bioprinters, Other), Bioinks (Natural Bioinks, Hybrid Bioinks, Synthetic Bioinks), Software, And Consumables. Based on Material, the market is segmented into liVing Cells, Hydrogels, Extracellular Matrices, And Other. Based on Application, the market is segmented into Research Applications (Drug Research, Regenerative Medicine, 3d Cells Culture), And Clinical Applications (Skin, Bone & Cartilage, Blood Vessels, Other). Based on Technology, the market is segmented into Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, And Others. Based on End-user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, And Hospitals. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Drivers of the Global 3D Bioprinting Market

Pharmaceutical companies are increasingly adopting 3D bioprinting technologies to enhance the discovery and development of new medications. Unlike traditional drug testing methods, 3D bioprinting offers a more cost-effective and safer alternative. This technology significantly accelerates the drug testing process, enabling pharmaceutical firms to evaluate a drug within hours rather than the three to six years typically required for new drug development. By using 3D-printed tissues, research and development teams can conduct early testing and preclinical trials more efficiently. The advantages of 3D bioprinting include reduced reliance on animal testing, improved productivity, and a faster drug development timeline. Additionally, the growing application of 3D printing in the cosmetic industry is contributing to market expansion. Since March 2013, the European Commission has prohibited animal testing for cosmetics. In response, some cosmetics and healthcare companies have turned to 3D bioprinting to create innovative 3D tissue models and develop new drug screening techniques, further driving the growth of this technology.

Restraints in the Global 3D Bioprinting Market

The high cost of equipment and bioinks necessary for producing functional tissues and organs presents a significant challenge for research institutions and medical facilities seeking to adopt and integrate 3D bioprinting technologies. Additionally, the complexity of the procedures and the need for skilled personnel further increase operational costs. These factors limit the widespread adoption and growth of 3D bioprinting. Consequently, the high expenses and technical barriers are restraining the expansion of the 3D bioprinting market.

Market Trends of the Global 3D Bioprinting Market

Burns and scars, especially on visible parts of the body, can significantly affect an individual's appearance. As consumer awareness of personal appearance rises, there is a growing demand for dermal surgeries and treatments worldwide. According to the National Institute on Aging, a substantial portion of individuals aged 16 to 33 is increasingly adopting advanced dermatological solutions. This trend is creating substantial opportunities for manufacturers of related products. The rising focus on self-care is a key driver behind the expansion of the 3D bioprinting market in developed regions. Additionally, 3D bioprinting technology is playing a crucial role in healthcare by facilitating the bioprinting of skin tissues, further contributing to market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Trade Analysis
  • Patent Analysis
  • Ecosystem of the Market
  • Customer & Buying Criteria Analysis
  • Regulatory Landscape
  • PESTEL Analysis
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Market Attractive Index
  • Degree of Competition

3D Bioprinting Market by Component

  • Market Overview
  • 3D Bioprinters
    • Micro Extrusion Bioprinters
    • Inkjet 3D Bioprinters
    • Laser-assisted Bioprinters
    • Stereolithography-based Bioprinters
    • Magnetic 3D Bioprinters
    • Other
  • Bioinks
    • Natural Bioinks
    • Hybrid Bioinks
    • Synthetic Bioinks
  • Software
  • Consumables

3D Bioprinting Market by Material

  • Market Overview
  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other

3D Bioprinting Market by Application

  • Market Overview
  • Research Applications
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical Applications
    • Skin
    • Bone & Cartilage
    • Blood Vessels
    • Other

3D Bioprinting Market by Technology

  • Market Overview
  • Magnetic Levitation
  • Inkjet-based
  • Syringe-based
  • Laser-based
  • Others

3D Bioprinting Market by End User

  • Market Overview
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals

3D Bioprinting Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • Italy
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Organovo Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3D Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CELLINK AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stratasys Ltd. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rokit Healthcare (Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Poietis SAS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aspect Biosystems Ltd. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cyfuse Biomedical K.K. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tissuelabs (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Advanced Solutions, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RegenHU Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Materialise NV (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microdrop Technologies GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeSiM mbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3D Biotek, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • REGEMAT 3D, SL (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • POIETIS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SUNP BIOTECH (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDPRIN (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PRODWAYS (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments